Better prognosis has also been described for patients with NSCLC with elevated calreticulin (CRT) expression on tumor cells that were, in turn, associated with a higher density of infiltrating mature DCs and effector memory T-cell subsets, thus suggesting that, in the TME, CRT triggers the activation of adaptive immune responses (90, 91). This evidence concerns the gene CALR and non-small cell lung carcinoma.